EP3675960 - COMPOSITION FOR USE OF SAME IN THE TREATMENT AND/OR PREVENTION OF INFERTILITY [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 23.02.2024 Database last updated on 13.11.2024 | |
Former | Grant of patent is intended Status updated on 02.01.2024 | ||
Former | Examination is in progress Status updated on 13.10.2022 | ||
Former | Request for examination was made Status updated on 05.06.2020 | ||
Former | The international publication has been made Status updated on 08.03.2019 | ||
Former | unknown Status updated on 03.09.2018 | Most recent event Tooltip | 01.11.2024 | Lapse of the patent in a contracting state New state(s): PL, RO, SK | published on 04.12.2024 [2024/49] | Applicant(s) | For all designated states AXEEN PHARMA S.A.R.L. 5, rue du Gabian Immeuble "Le Triton" Bloc B - 2ème étage 98000 Monaco / MC | [2022/52] |
Former [2020/28] | For all designated states Sérélys Pharma S.A.M. 5 Rue du Gabian 98000 Monaco / MC | Inventor(s) | 01 /
MORRA, Sossio 4 avenue des Ligures 98000 Monaco / MC | [2020/28] | Representative(s) | Axe PI 7, place Ile de Beauté 06300 Nice / FR | [2020/28] | Application number, filing date | 18758631.8 | 27.08.2018 | [2020/28] | WO2018EP73018 | Priority number, date | FR20170070894 | 28.08.2017 Original published format: FR 1770894 | [2020/28] | Filing language | FR | Procedural language | FR | Publication | Type: | A1 Application with search report | No.: | WO2019042934 | Date: | 07.03.2019 | Language: | FR | [2019/10] | Type: | A1 Application with search report | No.: | EP3675960 | Date: | 08.07.2020 | Language: | FR | The application published by WIPO in one of the EPO official languages on 07.03.2019 takes the place of the publication of the European patent application. | [2020/28] | Type: | B1 Patent specification | No.: | EP3675960 | Date: | 27.03.2024 | Language: | FR | [2024/13] | Search report(s) | International search report - published on: | EP | 07.03.2019 | Classification | IPC: | A61K36/15, A61K36/899, A61K31/355, A61P15/08, A61K31/122, A61K45/06 | [2024/02] | CPC: |
A61P15/08 (EP,US);
A61K36/15 (EP,US);
A61K31/01 (US);
A61K31/122 (EP,US);
A61K31/197 (US);
A61K31/355 (US);
A61K31/375 (US);
A61K31/4415 (US);
A61K31/525 (US);
A61K31/593 (US);
A61K31/714 (US);
A61K33/04 (US);
A61K33/30 (US);
A61K36/31 (US);
A61K36/899 (EP,US);
A61K45/06 (EP);
A61K9/0053 (US);
A61K9/2054 (EP);
A61K9/4866 (EP)
(-)
| C-Set: |
A61K31/122, A61K2300/00 (EP);
A61K36/15, A61K2300/00 (EP);
A61K36/899, A61K2300/00 (EP)
|
Former IPC [2020/28] | A61P15/08, A61K36/15, A61K36/899, A61K31/355 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/28] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | ZUSAMMENSETZUNG ZUR VERWENDUNG BEI DER BEHANDLUNG UND / ODER PRÄVENTION VON UNFRUCHTBARKEIT | [2020/28] | English: | COMPOSITION FOR USE OF SAME IN THE TREATMENT AND/OR PREVENTION OF INFERTILITY | [2020/28] | French: | COMPOSITION POUR SON UTILISATION DANS LE TRAITEMENT ET/OU LA PREVENTION DE L'INFERTILITE | [2020/28] | Entry into regional phase | 02.03.2020 | National basic fee paid | 02.03.2020 | Designation fee(s) paid | 02.03.2020 | Examination fee paid | Examination procedure | 02.03.2020 | Examination requested [2020/28] | 02.03.2020 | Date on which the examining division has become responsible | 30.09.2020 | Amendment by applicant (claims and/or description) | 12.10.2022 | Despatch of a communication from the examining division (Time limit: M06) | 14.02.2023 | Reply to a communication from the examining division | 01.12.2023 | Cancellation of oral proceeding that was planned for 07.12.2023 | 07.12.2023 | Date of oral proceedings (cancelled) | 03.01.2024 | Communication of intention to grant the patent | 20.02.2024 | Fee for grant paid | 20.02.2024 | Fee for publishing/printing paid | 20.02.2024 | Receipt of the translation of the claim(s) | Fees paid | Renewal fee | 02.03.2020 | Renewal fee patent year 03 | 30.07.2021 | Renewal fee patent year 04 | 08.07.2022 | Renewal fee patent year 05 | 29.08.2023 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 27.03.2024 | BG | 27.03.2024 | CZ | 27.03.2024 | EE | 27.03.2024 | FI | 27.03.2024 | HR | 27.03.2024 | LT | 27.03.2024 | LV | 27.03.2024 | PL | 27.03.2024 | RO | 27.03.2024 | SE | 27.03.2024 | SK | 27.03.2024 | SM | 27.03.2024 | NO | 27.06.2024 | RS | 27.06.2024 | GR | 28.06.2024 | IS | 27.07.2024 | PT | 29.07.2024 | [2024/49] |
Former [2024/48] | AT | 27.03.2024 | |
BG | 27.03.2024 | ||
CZ | 27.03.2024 | ||
EE | 27.03.2024 | ||
FI | 27.03.2024 | ||
HR | 27.03.2024 | ||
LT | 27.03.2024 | ||
LV | 27.03.2024 | ||
SE | 27.03.2024 | ||
SM | 27.03.2024 | ||
NO | 27.06.2024 | ||
RS | 27.06.2024 | ||
GR | 28.06.2024 | ||
IS | 27.07.2024 | ||
PT | 29.07.2024 | ||
Former [2024/47] | BG | 27.03.2024 | |
FI | 27.03.2024 | ||
HR | 27.03.2024 | ||
LT | 27.03.2024 | ||
LV | 27.03.2024 | ||
SE | 27.03.2024 | ||
SM | 27.03.2024 | ||
NO | 27.06.2024 | ||
RS | 27.06.2024 | ||
GR | 28.06.2024 | ||
IS | 27.07.2024 | ||
PT | 29.07.2024 | ||
Former [2024/46] | BG | 27.03.2024 | |
FI | 27.03.2024 | ||
HR | 27.03.2024 | ||
LT | 27.03.2024 | ||
LV | 27.03.2024 | ||
SE | 27.03.2024 | ||
NO | 27.06.2024 | ||
RS | 27.06.2024 | ||
GR | 28.06.2024 | ||
IS | 27.07.2024 | ||
Former [2024/37] | BG | 27.03.2024 | |
FI | 27.03.2024 | ||
HR | 27.03.2024 | ||
LT | 27.03.2024 | ||
LV | 27.03.2024 | ||
SE | 27.03.2024 | ||
NO | 27.06.2024 | ||
RS | 27.06.2024 | ||
GR | 28.06.2024 | ||
Former [2024/36] | BG | 27.03.2024 | |
FI | 27.03.2024 | ||
HR | 27.03.2024 | ||
LT | 27.03.2024 | ||
LV | 27.03.2024 | ||
NO | 27.06.2024 | ||
RS | 27.06.2024 | ||
GR | 28.06.2024 | ||
Former [2024/34] | BG | 27.03.2024 | |
FI | 27.03.2024 | ||
HR | 27.03.2024 | ||
LT | 27.03.2024 | ||
NO | 27.06.2024 | ||
RS | 27.06.2024 | ||
GR | 28.06.2024 | ||
Former [2024/33] | LT | 27.03.2024 | |
NO | 27.06.2024 | Cited in | International search | [IY]WO0217944 (NATUMIN PHARMA AB [SE]); | [YD]EP2135621 (FASANI ROBERTO [IT]); | [YD]FR2964834 (COHEN MARC [FR]); | by applicant | EP2135621 | FR2964834 |